Aurora Cannabis Inc. (ACB) News
Track canonical SquawkNews coverage tagged to ACB, Aurora Cannabis Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 32 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Aurora Cannabis: Intends to Demonstrate Curaleaf's Circular Hasn't Satisfied Several Regulatory Requirements >ACB
Aurora Cannabis: Intends to Demonstrate Curaleaf's Circular Hasn't Satisfied Several Regulatory Requirements >ACB
NEWS | Sep 23, 2026, 10:30 PM UTC
L
Aurora Cannabis: Application Filed With Alberta Securities Commission for Order Requiring Curaleaf to Comply With Securities Laws
Aurora Cannabis: Application Filed With Alberta Securities Commission for Order Requiring Curaleaf to Comply With Securities Laws
NEWS | Sep 23, 2026, 10:30 PM UTC
L
ACB - Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
ACB - Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
NEWS | Sep 23, 2026, 10:29 PM UTC
L
Aurora Cannabis Inc. (ACB) Seeks ASC Order on Curaleaf Bid Disclosures
Aurora filed an application with the Alberta Securities Commission alleging deficiencies in Curaleaf’s hostile bid circular and seeks corrections and a full 105-day deposit period.Material DetailsContext by AI AnalystThi
NEWS | Sep 23, 2026, 10:29 PM UTC
L
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
NASDAQ | TSX:ACBEDMONTON, AB, Sept. 23, 2026 /CNW/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today filed an application with t
NEWS | Sep 23, 2026, 10:29 PM UTC
H
Aurora Cannabis Re-Affirms FY27 Q2 Guidance For Sequential Growth In Quarterly Net Revenue And Adjusted EBITDA
Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA1 Following the receipt of EU-GMP certification in July, Safari Flower Company is expected to contribute incremental net reven
LIVE | Sep 16, 2026, 11:07 AM UTC
M
Aurora Cannabis reaffirms FY27 Q2 guidance for sequential quarterly revenue
Aurora Cannabis re-affirms its FY27 2Q guidance, citing sequential growth in quarterly net revenue.
EQUITY | Sep 16, 2026, 11:06 AM UTC
L
ACB - Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
ACB - Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
MNA | Sep 16, 2026, 11:05 AM UTC
L
ACB appoints biopharmaceutical executive to lead medical cannabis commercial acceleration
Aurora Cannabis (ACB) appoints a seasoned biopharmaceutical executive to lead commercial acceleration of its global medical cannabis business.
EQUITY | Sep 09, 2026, 11:06 AM UTC
L
Aurora Cannabis appoints Faris El Refaie to lead global commercial push
Aurora Cannabis says biopharmaceutical executive Faris El Refaie, with 25 years of experience, will join as Executive Vice President for Global Commercial operations.
EQUITY | Sep 09, 2026, 11:05 AM UTC
H
Bank of Canada keeps policy rate steady at 2.25%
Bank of Canada left its main interest rate unchanged at 2.25% and took a more alarmed tone on upside inflation risks tied to new cross-border tariffs and no imminent end to the war in the Middle East.
CENTRAL_BANK | Sep 02, 2026, 08:32 PM UTC
M
Aurora Cannabis urges shareholders to reject Curaleaf hostile bid
Aurora Cannabis urged shareholders to reject Curaleaf Holdings’ unsolicited $272 million hostile takeover offer, saying it is inadequate and undervalues parts of Aurora’s business.
MNA | Sep 02, 2026, 04:24 PM UTC
L
Curaleaf: 'Not Once Has There Been a Counteroffer Presented to Us'
Curaleaf: 'Not Once Has There Been a Counteroffer Presented to Us'
EQUITY | Sep 02, 2026, 03:20 PM UTC
L
ACB responds to Aurora circular, reiterates best value path
ACB responded to an Aurora circular and reaffirmed its offer as the best path to value creation for shareholders.
EQUITY | Sep 02, 2026, 03:18 PM UTC
L
Curaleaf offer undervalues Aurora medical business, CEO says
Curaleaf’s offer is seen as undervaluing Aurora’s medical cannabis business, according to the CEO.
EQUITY | Sep 02, 2026, 02:45 PM UTC
L
Aurora Cannabis open to different offers, CEO says
Aurora Cannabis says it remains open to different offers, per its CEO.
EQUITY | Sep 02, 2026, 02:45 PM UTC
L
Aurora Cannabis CEO: 'Medical Cannabis Is Probably the Best Part of the Cannabis Ecosystem' >CURA.T
Aurora Cannabis CEO: 'Medical Cannabis Is Probably the Best Part of the Cannabis Ecosystem' >CURA.T
EQUITY | Sep 02, 2026, 02:45 PM UTC
L
Aurora Cannabis CEO says Curaleaf bid undervalues business
Aurora Cannabis CEO Miguel Martin said Curaleaf's bid undervalues the business.
EQUITY | Sep 02, 2026, 02:45 PM UTC
H
Aurora Cannabis urges shareholders to reject Curaleaf hostile bid
Aurora Cannabis is urging shareholders to reject Curaleaf Holdings’ unsolicited $272 million hostile takeover offer, calling it inadequate and aimed at using Aurora’s clean balance sheet to absorb Curaleaf’s heavy debt l
MNA | Sep 02, 2026, 12:41 PM UTC
L
Aurora Cannabis urges shareholders to reject Curaleaf takeover bid
Aurora Cannabis says its board is unanimous in urging shareholders to reject Curaleaf Holdings’ unsolicited takeover bid, calling it an undervaluation of Aurora’s current business and future potential.
MNA | Sep 02, 2026, 11:56 AM UTC
L
Aurora Cannabis says Curaleaf bid undervalues company
Aurora Cannabis said Curaleaf’s bid undervalues the company.
EQUITY | Sep 02, 2026, 11:08 AM UTC
M
Aurora Cannabis urges shareholders to reject Curaleaf hostile bid
Aurora Cannabis says Curaleaf’s hostile bid is inadequate, undervalues Aurora, and risks shareholder value and future upside.
EQUITY | Sep 02, 2026, 11:05 AM UTC
L
ACB - Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
ACB - Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
EQUITY | Aug 24, 2026, 07:46 PM UTC
L
Aurora Cannabis special committee has not yet recommended Curaleaf offer
Aurora Cannabis says its special committee of the board has not yet made a formal recommendation regarding the Curaleaf offer.
MNA | Aug 24, 2026, 11:10 AM UTC
L
Aurora Cannabis corrects statements supporting Curaleaf hostile bid
Aurora Cannabis says it is correcting inaccurate statements made in support of Curaleaf Holdings' hostile bid.
MNA | Aug 24, 2026, 11:06 AM UTC
M
Aurora Cannabis acquires Internode Pharma and HAP Pharma
Aurora Cannabis says it is acquiring Internode Pharma Limited and HAP Pharma Limited to expand distribution access to the UK medical cannabis market.
MNA | Aug 19, 2026, 05:46 PM UTC
H
Aurora Cannabis urges no action on Curaleaf unsolicited bid
Aurora Cannabis (ACB) urges shareholders to take no action at this time regarding Curaleaf Holdings’ unsolicited take-over bid.
MNA | Aug 19, 2026, 11:06 AM UTC
L
Trading Halt: Halt status updated at 4:15:00 PM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt status updated at 4:15:00 PM ET: Quotation Resumption: News and Resumption Times
EQUITY | Aug 11, 2026, 08:15 PM UTC
L
Aurora Cannabis Says Board To Form Special Committee To Review Curaleaf's Unsolicited $4.00 Per Share Take-Over Proposal; Says $5.00 Cap Bel
Aurora Cannabis Says Board To Form Special Committee To Review Curaleaf's Unsolicited $4.00 Per Share Take-Over Proposal; Says $5.00 Cap Below December 2025 Trading Levels
EQUITY | Aug 11, 2026, 07:28 PM UTC
H
Aurora Cannabis Responds To Curaleaf Takeover Bid
Aurora Cannabis responds to Curaleaf's intention to launch an unsolicited takeover bid
MNA | Aug 11, 2026, 07:23 PM UTC
L
ACB ACB ACB - Aurora Cannabis Announces Fiscal 2027 First Quarter Results
ACB ACB ACB - Aurora Cannabis Announces Fiscal 2027 First Quarter Results
EARNINGS | Aug 05, 2026, 11:02 AM UTC
L
ACB Aurora Cannabis Unit Safari Flower Receives EU-GMP Certification at Niagara Facility
ACB Aurora Cannabis Unit Safari Flower Receives EU-GMP Certification at Niagara Facility
EQUITY | Jul 23, 2026, 11:17 AM UTC